Member Info for Cliostock

What do you suggest is the relevance of Sederma’s rivals catching on? Do you infer that Croda may allow the rivals of Sederma to buy the lysate? We know Croda have exclusivity for the life of the patent, why would they sell to rivals of their own group company?

The product Elrico mentions is picking up plenty of industry accolades, namely awards and honourable mentions, so even if it is not our product, it shows what lines Croda will go down with our technology when launched.

I do have a question whilst you are around Elric. Any NDA’s I’ve ever signed for work have contained some kind of clause releasing me from the NDA once the protected information becomes public knowledge. If you have hit upon the product in your piece, do you think this might make its announcement by Stuart a bit quicker than it otherwise would have been, given it has now been in the public domain?

Ironic that Oleric accuses Elrico of posting rubbish. Umm. Pot calling the kettle black. Surely there’s better things you can think of to post about this multifaceted company for the board to discuss. The SP is up 32% in the past 30 days and we’ve still got schoolyard sniping! I’d rather listen to the great Elrico posting fresh opinions than the grating Oleric posting stale ramblings.

Extended steady rises never mean bad news, just either good news or returning sentiment. I like the fact that the market doesn’t seem to know what is behind the rise. It’s the first time here I’ve seen a good rise that isn’t because the market has some kind of strong expectations which just sets us up for a fall when the real news lands. I hope no reasoning is able to be attributed to it for once, so that when the news, if any, is announced, it’s a surprise to the market and the buying can continue based on the nice surprise rather than being compared to over egged expectations. GLA LTH!

DireCons, depending on your starting price, you’ve done very well to trade an average down to low twenties here. I hope you feel as confident of very strong returns from that level that I would. Personally, I don’t like to trade, but it is respected that people do.

Do we think that the rises over the last few days have been a single large order being fulfilled? Either way, we win when the price is moving like it has been.

It’s been an unusual couple of days, hasn’t it Farris. I tried a £1300 top up after my comment earlier, which I was going to mention as evidence of my belief in Stuart to achieve what he thinks he can achieve - the share price ran away from my limit order. But the way things have been going I expect we will open lower on Monday, before recovering during the day.

Those of us that know the company well know that it is capable of carrying a share price many multiple of what it is today. You’re right Bel when you insinuate it rests on Stuart. What he does, and when. I do feel the longer these deals take after having being teased, the less impact they will have.

Let’s hope the buying continues into tomorrow. Twice this month we have been a featured share riser in the daily LSE Market Report email. Once as one of the main share risers and once in the top performing sector section. Hopefully this is an early sign of buying into the plethora of expected news.

I’ve just tried for the third time, nowhere to be seen. Closed the tab then reopened Google and searched again and there is was, first page at the top. It looks like there are a few companies competing for the keywords at the moment.

Just repeated with suggested settings and still nowhere. However psoriasis treatment is a broad term and it’s positive to see it’s appearing prominently on some screens. I think it would be unreasonable to expect it to hit us all when we know marketing spend is low.

Aquae, just replicated the search myself and unfortunately Axis or Skinbio is nowhere to be seen on my device. I’ve given up after 5 pages of results. We know they don’t have a huge marketing budget, so I don’t blame them, just being balanced.

I have faith too Joy.
We certainly do need luck, but the harder you work the luckier you get, and our team are working hard.
I’ve been in for years too and I know there’s plenty more like us. I also know there are lots of PI’s and some of the larger investors have positions in the 40’s, 50’s and 60’s, which should reduce profit taking each time we do have a 5/10/20% increase. We need Stuart to drop the bombs he’s building, and hopefully we’ll get the sentiment back that we had when we went from 22p to 67p at the start of 2021. (Before we had tangible products and revenue.)

Happy as you guys to see the rise today, but I don’t think anyone will be able to tell you exactly why. My own opinion is that we will have a few of these incremental rises up to the time when the market is expecting news on Croda. Then, as much as I hate to say it, if we haven’t had anything by Christmas it will start to walk right back down again.

Weren’t we led to believe the USA had different order numbering?

I’m sure the results at the end of next month will provide some clarity, after all, Stuart has vowed to communicate much more clearly in RNS’s from now on.

I believe him when he says he doesn’t need to raise. I understand that on the face of it this may contrast somewhat to previous RNS’s as copied in by Aquae, but he knows much more than we do. If Skinbiotix is already generating revenue, he’ll know and that would justify his confidence.

Great not create *

I’d also suggest listening back to Elrics last interview with Stuart, there is a lot spoken about and is create for dampening down the part of us that naturally wants news every day. It’s also natural that these deals take time, but have a listen and rest assured it’s coming.

https://youtu.be/eZsW0tVnpCs

In certain circumstances it may be questionable but it’s an honest review, delivered after using the product and seems like a well balanced opinion. Nothing wrong with this at all.

Yes a good find. What was interesting about the link provided was to see the ambassadors with Psoriasis are from each and every corner of the globe. I had assumed the Psoriasis was much more prevalent in northern & western Europe with our pale skin type, with sun kissed countries having generally healthier skin. Not the case, which is good for sales trajectory once the product has begun to get traction in the U.K. and USA.

Just had another read down the TP reviews, haven’t looked for a while. Great to see the number of people raving about it seem to be continuously growing. Also interesting to see a few people claiming it to have worked for other skin conditions. I look forward to knowing what the current sales are like. Hopefully we find out when we get the full year results at the end of November/ beginning of December, if not before.